Potential Interventions for Novel Coronavirus in China: A Systematic Review

Overview

Journal J Med Virol

Specialty Microbiology

Date 2020 Feb 14

PMID 32052466

Citations 553

Authors

Lei Zhang

Yunhui Liu

Affiliations

Soon will be listed here.

Abstract

An outbreak of a novel coronavirus (COVID-19 or 2019-CoV) infection has posed significant threats to international health and the economy. In the absence of treatment for this virus, there is an urgent need to find alternative methods to control the spread of disease. Here, we have conducted an online search for all treatment options related to coronavirus infections as well as some RNA-virus infection and we have found that general treatments, coronavirus-specific treatments, and antiviral treatments should be useful in fighting COVID-19. We suggest that the nutritional status of each infected patient should be evaluated before the administration of general treatments and the current children's RNA-virus vaccines including influenza vaccine should be immunized for uninfected people and health care workers. In addition, convalescent plasma should be given to COVID-19 patients if it is available. In conclusion, we suggest that all the potential interventions be implemented to control the emerging COVID-19 if the infection is uncontrollable.

Citing Articles

Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study.

Al Balawi A, Eldiasty J, Mosallam S, El-Alosey A, Elmetwalli A Bioresour Bioprocess. 2024; 11(1):108.

PMID: 39604740 PMC: 11602940. DOI: 10.1186/s40643-024-00822-z.

Antiseptics: An expeditious third force in the prevention and management of coronavirus diseases.

Okeke K, Ahamefule C, Nnabuife O, Orabueze I, Iroegbu C, Egbe K Curr Res Microb Sci. 2024; 7:100293.

PMID: 39497935 PMC: 11532748. DOI: 10.1016/j.crmicr.2024.100293.

Nitric Oxide Signaling and Sensing in Age-Related Diseases.

Mazuryk O, Gurgul I, Oszajca M, Polaczek J, Kieca K, Bieszczad-Zak E Antioxidants (Basel). 2024; 13(10).

PMID: 39456466 PMC: 11504650. DOI: 10.3390/antiox13101213.

Strategies and bibliometric analysis of legumes biofortification to address malnutrition.

Altaf M, Liaqat W, Jamil A, Jan M, Baloch F, Barutcular C Planta. 2024; 260(4):85.

PMID: 39227398 DOI: 10.1007/s00425-024-04504-0.

Evaluation and comparison of one-step real-time PCR and one-step RT-LAMP methods for detection of SARS-CoV-2.

Hanifehpour H, Ashrafi F, Siasi E, Fallahi S BMC Infect Dis. 2024; 24(1):679.

PMID: 38982392 PMC: 11232332. DOI: 10.1186/s12879-024-09574-9.

References

Leong H, Earnest A, Lim H, Chin C, Tan C, Puhaindran M . SARS in Singapore--predictors of disease severity. Ann Acad Med Singap. 2006; 35(5):326-31. View

Marriott I, Huet-Hudson Y . Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res. 2006; 34(3):177-92. DOI: 10.1385/IR:34:3:177. View

Panche A, Diwan A, Chandra S . Flavonoids: an overview. J Nutr Sci. 2017; 5:e47. PMC: 5465813. DOI: 10.1017/jns.2016.41. View

ZARUBA K, Rastorfer M, Grob P, Bolla K . Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination. Lancet. 1983; 2(8361):1245. DOI: 10.1016/s0140-6736(83)91284-9. View

Akerstrom S, Mousavi-Jazi M, Klingstrom J, Leijon M, Lundkvist A, Mirazimi A . Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol. 2005; 79(3):1966-9. PMC: 544093. DOI: 10.1128/JVI.79.3.1966-1969.2005. View

Jo S, Kim H, Kim S, Shin D, Kim M . Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem Biol Drug Des. 2019; 94(6):2023-2030. PMC: 7162010. DOI: 10.1111/cbdd.13604. View

Loutfy M, Blatt L, Siminovitch K, Ward S, Wolff B, Lho H . Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA. 2003; 290(24):3222-8. DOI: 10.1001/jama.290.24.3222. View

Guillin O, Vindry C, Ohlmann T, Chavatte L . Selenium, Selenoproteins and Viral Infection. Nutrients. 2019; 11(9). PMC: 6769590. DOI: 10.3390/nu11092101. View

Escriou N, Callendret B, Lorin V, Combredet C, Marianneau P, Fevrier M . Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein. Virology. 2014; 452-453:32-41. PMC: 7111909. DOI: 10.1016/j.virol.2014.01.002. View

10.

Alghamdi I, Hussain I, Almalki S, Alghamdi M, Alghamdi M, El-Sheemy M . The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J Gen Med. 2014; 7:417-23. PMC: 4149400. DOI: 10.2147/IJGM.S67061. View

11.

West C, Sijtsma S, Kouwenhoven B, Rombout J, Van der Zijpp A . Epithelia-damaging virus infections affect vitamin A status in chickens. J Nutr. 1992; 122(2):333-9. DOI: 10.1093/jn/122.2.333. View

12.

Blaising J, Polyak S, Pecheur E . Arbidol as a broad-spectrum antiviral: an update. Antiviral Res. 2014; 107:84-94. PMC: 7113885. DOI: 10.1016/j.antiviral.2014.04.006. View

13.

Ter Meulen J, Bakker A, van den Brink E, Weverling G, Martina B, Haagmans B . Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet. 2004; 363(9427):2139-41. PMC: 7112500. DOI: 10.1016/S0140-6736(04)16506-9. View

14.

Jee J, Hoet A, Azevedo M, Vlasova A, Loerch S, Pickworth C . Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine. Am J Vet Res. 2013; 74(10):1353-62. DOI: 10.2460/ajvr.74.10.1353. View

15.

Bijlenga G . Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The Netherlands. J Infect. 2005; 51(3):263-5. PMC: 7119113. DOI: 10.1016/j.jinf.2005.04.010. View

16.

Kuri T, Zhang X, Habjan M, Martinez-Sobrido L, Garcia-Sastre A, Yuan Z . Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J Gen Virol. 2009; 90(Pt 11):2686-2694. PMC: 2888313. DOI: 10.1099/vir.0.013599-0. View

17.

Hemila H . Vitamin C intake and susceptibility to pneumonia. Pediatr Infect Dis J. 1997; 16(9):836-7. DOI: 10.1097/00006454-199709000-00003. View

18.

Booth C, Matukas L, Tomlinson G, Rachlis A, Rose D, Dwosh H . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21):2801-9. DOI: 10.1001/jama.289.21.JOC30885. View

19.

Costantini C, Bellet M, Pariano M, Renga G, Stincardini C, Goldstein A . A Reappraisal of Thymosin Alpha1 in Cancer Therapy. Front Oncol. 2019; 9:873. PMC: 6742685. DOI: 10.3389/fonc.2019.00873. View

20.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View